G

Guardant Health

FDA-approved blood-based cancer diagnostics provider

Medical Lead

Biology & BiotechUpdated on Nov 14
Full-timeHyderabad, Telangana, IndiaNo salary listed

About the Job

Requirements

  • A minimum of an MD, MBBS, PhD, PharmD, MSc, or equivalent advanced degree in medicine, oncology, pathology, molecular biology, genomics, or a related discipline.
  • At least 5 years of relevant experience in Medical Affairs, oncology diagnostics, precision oncology, molecular pathology, next-generation sequencing, biotech, or oncology pharmaceuticals.
  • Demonstrated experience engaging oncology key opinion leaders, academic centres, pathologists, molecular laboratories, multidisciplinary clinical teams, or cancer care institutions.
  • Ability to interpret oncology genomics, molecular diagnostics, and clinical evidence and translate complex scientific information for clinical and non-clinical audiences.
  • Experience contributing to publications, abstracts, medical education programs, advisory boards, evidence-generation activities, or scientific communication initiatives.
  • Strong understanding of Medical Affairs governance, scientific exchange principles, and compliant cross-functional collaboration.
  • Strong stakeholder management, cross-functional collaboration, and project management skills.
  • Proficiency with Microsoft Office applications including PowerPoint, Excel, and Word, and virtual engagement platforms.
  • Ability to work independently, handle frequent travel, and manage a multi-task workload in a fast-paced environment.
  • Ability to critically evaluate and responsibly use AI-enabled tools in accordance with company policies, ethical standards, and regulatory requirements.
  • Ability to sit for extended periods and perform routine office equipment use; the role may involve exposure to high noise levels, fumes, and biohazard material in a laboratory environment.

Responsibilities

  • Contribute to country-level evidence gap analysis and co-develop the India evidence and publication roadmap in alignment with AMEA and global Medical Affairs priorities.
  • Develop territory-specific medical plans reflecting local oncology care pathways, molecular diagnostics adoption, stakeholder needs, and evidence requirements.
  • Identify, design, and support company-sponsored studies, real-world evidence initiatives, clinical utility projects, and investigator-initiated studies in assigned territories.
  • Support study feasibility, protocol review, site engagement, investigator discussions, timelines, milestone tracking, and risk mitigation.
  • Support the development and quality review of abstracts, posters, manuscripts, congress submissions, and evidence packages.
  • Partner with regional Medical Affairs and cross-functional teams to ensure local evidence generation is scientifically robust, compliant, and aligned with business and patient access priorities.
  • Build and maintain scientific relationships with oncologists, pathologists, molecular laboratories, academic institutions, cancer centres, payers, public health stakeholders, and other relevant experts in assigned territories.
  • Develop and deliver scientific education, including presentations, grand rounds, continuing medical education programs, advisory boards, tumour board discussions, and internal and external training sessions.
  • Provide on-site and virtual clinical support for complex case discussions, report interpretation, molecular tumour boards, and multidisciplinary meetings.
  • Train external speakers, distributors, and internal teams on scientific topics, clinical evidence, testing pathways, and appropriate use of company products.
  • Capture, synthesize, and communicate medical insights from key opinion leader interactions, conferences, advisory boards, tumour boards, and field activities to inform country and regional strategy.
  • Provide compliant, evidence-based medical input to Commercial, Marketing, Client Services, Market Access, Regulatory, and distributor teams.
  • Advise cross-functional teams on clinical strategy, scientific messaging, value narratives, payer evidence requirements, customer education needs, and territory-specific stakeholder dynamics.
  • Review scientific and promotional materials for alignment with clinical evidence, internal standards, applicable regulations, and company compliance requirements.
  • Support distributor medical activities, including training, scientific oversight, field medical support, and alignment with company standards.
  • Partner with Market Access and Commercial teams to support evidence-based payer and institutional engagement while maintaining appropriate Medical Affairs independence.
  • Represent assigned territories in India Medical Affairs planning and contribute to regional AMEA Medical Affairs initiatives.
  • Track territory-level Medical Affairs key performance indicators, deliverables, and impact measures, including evidence-generation progress, key opinion leader engagement quality, educational programs, insight generation, and cross-functional support.
  • Report progress, risks, and opportunities to the Director, Regional Medical Affairs – AMEA.
  • Maintain accurate documentation of stakeholder interactions, medical insights, educational activities, and project milestones.
  • Conduct all activities in accordance with ethical, legal, regulatory, and compliance requirements, including local laws, company standard operating procedures, and company policies.
  • Travel frequently to engage key opinion leaders, attend conferences, and conduct on-site activities; travel ranges from regular weekly short trips to approximately 40–50%, depending on business needs and the conference calendar. Some weekend or evening work may be required for scientific meetings.

Desired Qualifications

  • Clinical background in oncology, such as medical oncology or molecular pathology.
  • Hands-on experience designing clinical utility or real-world evidence studies and/or supporting health technology assessment or payer dossiers.
  • Track record of first-author or lead contributions to peer-reviewed publications and conference presentations.
  • Additional regional languages.

About the Company

Guardant Health

FDA-approved blood-based cancer diagnostics provider

Guardant Health develops blood-based cancer diagnostics and sells tests to healthcare providers and research institutions. Its flagship product, Guardant360, uses a liquid biopsy to analyze tumor DNA circulating in a patient’s blood to detect mutations and guide treatment decisions for advanced cancer. The company is expanding into early detection and recurrence monitoring, with tests designed to be non-invasive and data-rich for cancer management. Compared with competitors, Guardant Health emphasizes a widely adopted, FDA-approved liquid biopsy platform with broad cancer-type coverage and a focus on providing actionable genomic insights to clinicians. Its goal is to improve cancer outcomes by enabling non-invasive, data-driven decision making across stages of disease and over time.

Company size
1,001-5,000
Company stage
IPO
Headquarters
Palo Alto, CA
Founded
2012

Recently Posted Jobs

Explore more opportunities at Guardant Health

See more jobs